Actively Recruiting
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-01-16
102
Participants Needed
1
Research Sites
54 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cancer treatments, despite their increasing effectiveness, carry a significant risk of gamete toxicity. Women of reproductive age are commonly offered fertility preservation (FP) before starting their treatment. However, few studies have analyzed the long-term reproductive outcomes of these interventions, nor how patients ultimately use or do not use the FP options once in remission. This project aims to better understand the effectiveness, utilization, and psychological impacts of these strategies. This work is part of an effort to understand and evaluate fertility preservation practices implemented for women of reproductive age undergoing cancer treatment at the Amiens-Picardie University Hospital (CHU). Its objective is to document patient pathways, clinical decisions, techniques employed, and reproductive outcomes observed after remission, in order to identify potential areas for improvement in the support and follow-up of these patients, thereby enhancing the overall quality and coordination of care. This work is conducted alongside the development of a fertility observatory at the Department of Medicine and Reproductive Biology, CHU Amiens-Picardie.
CONDITIONS
Official Title
Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged between 18 and 47 years
- Diagnosed with cancer or hematological disorders requiring potentially fertility-harming treatment
- Have undergone a medical fertility preservation consultation
- Followed at Amiens Picardie University Hospital in the department of Reproductive Medicine
- Currently in remission
- Have expressed non-opposition to participation in the study
You will not qualify if you...
- Not in remission
- Deprived of liberty by administrative or judicial decision, or under legal protection (guardianship or curatorship)
- Decline to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens Picardie
Amiens, France
Actively Recruiting
Research Team
C
CABRY-GOUBET Rosalie, Pr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here